Recent content from Joe Carlson
In March 2015, Target Corp. alerted customers to throw out certain 10-ounce bags of organic chopped spinach because they were potentially contaminated with listeria bacteria,…
Medtronic's latest deal was another step in expanding the use of home-monitoring devices as it tries to cater to patients
Trade group says device price cap dispute is "existential threat."
A spokesman for the device maker said it hasn't been able to access the facilities to assess damage.
Medtronic ordered its employees at Santa Rosa device facilities to leave.
About 23 medical device companies including Medtronic and Boston Scientific have facilities on the island, including manufacturing sites that churn out everything from pacemakers to trauma-surgery products.
The maker of implantable medical devices for weight loss will keep a Minnesota office.
Public hearings on the opioid crisis are expected to take place at the State Capitol just after the start of the new year.
If the world wants alternatives to habit-forming opioid drugs for pain, it can look to Minnesota for answers.
The Bair Hugger blanket is the target of lawsuits, but the FDA said it has found no evidence that such devices cause infections.
Locating workers, assessing damage among first challenges in storm-ravaged Puerto Rico.
After acquiring St. Jude, it lost defibrillator market share to Medtronic and Boston Scientific.
Many major device companies have manufacturing operations in path of Maria.
The federal lawsuit alleges that St. Jude knew more than 250,000 defibrillators it sold in the United States between 2011 and October 2016 contained batteries that could abruptly short out.
Firm is latest device maker to acknowledges problems; no hacking reports yet received.
The device delivers mild current to spine that disrupts pain signals before they can travel to the brain.The company said it can be securely controlled with a Samsung tablet.
Mayo Clinic, Amazon team up to form a new voice-activated system for dispensing reliable medical advice at home.
Bob Hauser is fun at dinner parties. He entertains, he tells old stories, and occasionally the retired cardiologist will diagnose a friend’s atrial fibrillation…
The decision to halt sales comes after Boston Scientific backed away from developing a rival product.
Firm wants data on best dosage of controversial bone-growth product.
Device maker is exclusive distributor for Mazor's robotics spine systems.
Six years after paying $800 million to acquire a startup company that made a medical device to lower high blood pressure, Medtronic this week presented…
The move occurs after an FDA-confirmed report about devices being vulnerable to hackers.
The HeartMate 3 device is among key products in the St. Jude Medical portfolio.
The FDA promised a nationwide crackdown on "unscrupulous" stem cell clinics, following years of reports that some clinics have offered lofty claims of potential medical benefits with scant, if any, medical evidence.
A computer outage trimmed sales during quarter, but CEO Omar Ishrak said the system is now working normally.
Roseville-based Rebiotix launched a clinical trial this month to test its treatment for C. diff infections.
State high court gives OK for shareholders to proceed.
Judge ruled the test results are products of the laws of nature, can't be patented.
Minnetonka-based Osprey Medical has raised about $26 million to bolster its U.S. sales force and ramp up efforts to sell medical devices that reduce the…
The device can provide data on heart performance in about 20 minutes at a cost of $100 or less.
With a national debate raging, Leigh Turner has taken center stage in questioning whether many of these services are legitimate.
Miromatrix is developing a process that transforms pig livers for use in humans through "reseeding" a white collagen shell.
The previously announced deal involves lower-margin products widely used in hospitals.
Although the company said the concept shows promise, it's opted to pursue other priorities.
Medical surgical supply sales offset slower growth in implantable devices, the company reported.
"Pops! one" would allow for glucose-level testing on the go, with just a tiny stick.
The two were working together months before the nearly $30B sale was finalized in January.
Profit still expected to hit low end of forecast for the May-through-July period.
Focus will be on new therapies for rare illnesses.
U.S. House measure would allow more time for them to be sent to the FDA.
Acquisition of Spirox could bolster its growth this year by 8 percentage points.
Stemonix products allow doctors to see how drugs and human cells react without risking a person's health.
Laura Brod has trod an unusual path into biotech, so perhaps it's not surprising that the company she leads is charting an unorthodox route.
Medtronic did not release figures for the confidential settlements. The company reported that it set aside $300 million for all of its legal settlements in the fiscal year that ended in April, according to the Securities and Exchange Commission filing.
Medtronic computers had been out for a full week, disrupting operations.
Costs would spike for 66,000 if Children's and Blue Cross can't agree.
Minnesota is a big player in the growing market for tools that are less invasive.
No patient harm reported from products made by Minn.'s Vascular Solutions.
A global computer outage has hurt Medtronic's ability to fulfill orders.
Blue Cross customers will not be covered there if no deal is reached by July 5.
Eden Prairie company, new partner to have a catalog of 7,000 products based in Twin Cities.
Incident happened hours after dueling protests over Islam.
In a push to increase use of its Tyrx envelope, company vows to share replacement cost should an infection set in.
Dr. Uzma Samadani is nearing a way to assess functions in real time.
India's government has ordered a big price cut; device firms are threatening to leave.
A Minneapolis firm's device is designed to help people sidelined with nerve damage regain the ability to walk
The medical device giant's guidance for year ahead is viewed by some as conservative.
The deaths occurred after patients tried to perform routine maintenance on their HeartMate II blood pump, made by the former St. Jude Medical. A "recall" notice urges that the upgrades be done in a clinic or hospital.
Hospital and medical device experts say well-meaning agencies did not coordinate attempts to provide — or always provide the most useful — information.
Experts will look to make recommendations to protect medical devices.
Patients with complex cardiac cases may benefit most from Acist Medical Systems device.
The trial between Boston Scientific and Medtronic minimally-invasive valves hints at a more competitive market.
Minnesota's IT experts had a tense and busy weekend.
Self-described whistleblower Muddy Waters accuses firm of trying to silence its critics.
Medtronic implant detects atrial fibrillation in high-risk patients.
The companies presented the results on heart devices at a Chicago conference.
Christopher M. Barry took design files to his new company when he left Lutonix.
Abbott's stimulation system can be controlled with an iPod, and is seen as the first big advancement in the U.S. in 20 years
After investing in the Maple Grove heart valve company in 2012, LivaNova is buying the company.
PraeVeni is working to implement what it calls a new test to accurately rule out the 10 most common heart problems for a fraction of the typical $4,000-plus cost of screening.
Recent FDA warning over seven patients implanted after recall could be a PR "black eye" for Abbott.
The company was faulted for failing to investigate defibrillator battery problems and cybersecurity shortcomings.
Mpls. hosted meeting to show off a brave new biotech world.
Valve was approved for use less than a year ago.
More from Star Tribune